358 related articles for article (PubMed ID: 15322741)
1. Significance of Bio-intact PTH(1-84) assay in hemodialysis patients.
Inaba M; Okuno S; Imanishi Y; Ueda M; Yamakawa T; Ishimura E; Nishizawa Y
Osteoporos Int; 2005 May; 16(5):517-25. PubMed ID: 15322741
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.
Okuno S; Inaba M; Kitatani K; Ishimura E; Yamakawa T; Nishizawa Y
Osteoporos Int; 2005 May; 16(5):501-9. PubMed ID: 15309383
[TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients.
Ueda M; Inaba M; Okuno S; Nagasue K; Kitatani K; Ishimura E; Shimizu M; Miki T; Kim M; Nishizawa Y
Am J Kidney Dis; 2002 Oct; 40(4):802-9. PubMed ID: 12324916
[TBL] [Abstract][Full Text] [Related]
4. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure.
Tsuchida T; Ishimura E; Miki T; Matsumoto N; Naka H; Jono S; Inaba M; Nishizawa Y
Osteoporos Int; 2005 Feb; 16(2):172-9. PubMed ID: 15164161
[TBL] [Abstract][Full Text] [Related]
6. Positive correlation of serum bio-intact PTH(1-84) but not intact PTH with parathyroid gland size in hemodialysis patients.
Inaba M; Okuno S; Chou H; Imanishi Y; Ueda M; Yamakawa T; Ishimura E; Nishizawa Y
Biomed Pharmacother; 2006 Feb; 60(2):62-5. PubMed ID: 16460905
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients.
Shidara K; Inaba M; Okuno S; Yamada S; Kumeda Y; Imanishi Y; Yamakawa T; Ishimura E; Nishizawa Y
Calcif Tissue Int; 2008 Apr; 82(4):278-87. PubMed ID: 18421493
[TBL] [Abstract][Full Text] [Related]
8. Serum N-terminal midfragment vs. intact osteocalcin immunoradiometric assay as markers for bone turnover and bone loss in hemodialysis patients.
Nagasue K; Inaba M; Okuno S; Kitatani K; Imanishi Y; Ishimura E; Miki T; Kim M; Nishizawa Y
Biomed Pharmacother; 2003 Mar; 57(2):98-104. PubMed ID: 12842495
[TBL] [Abstract][Full Text] [Related]
9. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?
Avbersek-Luznik I; Balon BP; Rus I; Marc J
Nephrol Dial Transplant; 2005 Mar; 20(3):566-70. PubMed ID: 15665031
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of cross-linked N-telopeptides of type I collagen: new marker for bone resorption in hemodialysis patients.
Maeno Y; Inaba M; Okuno S; Yamakawa T; Ishimura E; Nishizawa Y
Clin Chem; 2005 Dec; 51(12):2312-7. PubMed ID: 16223890
[TBL] [Abstract][Full Text] [Related]
11. Function of parathyroid glands in kidney transplant patients--diagnostic value of CAP and CIP.
Spiechowicz U; Kokot F; Wiecek A
Ann Transplant; 2004; 9(3):33-6. PubMed ID: 15759544
[TBL] [Abstract][Full Text] [Related]
12. Serum adiponectin and bone mineral density in male hemodialysis patients.
Okuno S; Ishimura E; Norimine K; Tsuboniwa N; Kagitani S; Yamakawa K; Yamakawa T; Sato KK; Hayashi T; Shoji S; Nishizawa Y; Inaba M
Osteoporos Int; 2012 Jul; 23(7):2027-35. PubMed ID: 21927917
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of osteocalcin and CrossLaps as markers of bone turnover in children with chronic renal failure].
Polak-Jonkisz D; Zwolińska D; Bednorz R; Owczarek H; Nahaczewska W
Pol Merkur Lekarski; 2002 Apr; 12(70):257-60. PubMed ID: 12089882
[TBL] [Abstract][Full Text] [Related]
14. [Skeletal scintigraph and some bone turnover markers in the diagnosis of renal osteodystrophy in hemodialysis patients].
Bednarek-Skublewska A; Chrapko B; Ksiazek A
Pol Arch Med Wewn; 2003 Sep; 110(3):943-50. PubMed ID: 14699686
[TBL] [Abstract][Full Text] [Related]
15. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay.
Cantor T; Sci B
Nefrologia; 2003; 23 Suppl 2():69-72. PubMed ID: 12778858
[TBL] [Abstract][Full Text] [Related]
16. Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients.
Kobayashi I; Shidara K; Okuno S; Yamada S; Imanishi Y; Mori K; Ishimura E; Shoji S; Yamakawa T; Inaba M
Life Sci; 2012 Jan; 90(5-6):212-8. PubMed ID: 22154904
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of PTH (1-84) and PTH (7-84) in patients with predialysis chronic renal failure in relation to bone metabolism markers].
Tsuchida T; Ishimura E; Hirowatari K; Matsumoto N; Jono S; Miki T; Inaba M; Nishizawa Y
Clin Calcium; 2005 Sep; 15 Suppl 1():156-60; discussion 160. PubMed ID: 16272650
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic value of PTH total kit for estimation of bone turnover in children with chronic renal failure].
Ziółkowska H; Roszkowska-Blaim M
Przegl Lek; 2006; 63 Suppl 3():149-52. PubMed ID: 16898516
[TBL] [Abstract][Full Text] [Related]
19. Influence of nutritional status on serum large N-truncated PTH, but not PTH(1-84) in hemodialysis patients.
Shidara K; Inaba M; Okuno S; Imanishi Y; Yamakawa T; Ishimura E; Kumeda Y; Nishizawa Y
Biomed Pharmacother; 2007; 61(2-3):142-7. PubMed ID: 17270383
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of 1-84 and 7-84 parathyroid hormone in predialysis patients with chronic renal failure measured by the intact and bio-PTH assay.
Tsuchida T; Ishimura E; Hirowatari K; Matsumoto N; Imanishi Y; Jono S; Miki T; Inaba M; Nishizawa Y
Nephron Clin Pract; 2006; 102(3-4):c108-14. PubMed ID: 16286785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
